Biology Seminar Series- Class of '88 Talks
- Sponsored by:
- Biology
Brigette Widemann, National Cancer Institute
“Development of effective therapies for neurofibromatosis type 1 related peripheral nerve sheath tumors”
About the talk: This talk will describe the genetic tumor predisposition syndrome NF1 and the history of how the team and collaborators developed the first FDA approved medical therapy for NF1 peripheral nerve sheath tumors.
“Development of effective therapies for neurofibromatosis type 1 related peripheral nerve sheath tumors”
About the talk: This talk will describe the genetic tumor predisposition syndrome NF1 and the history of how the team and collaborators developed the first FDA approved medical therapy for NF1 peripheral nerve sheath tumors.
McCardell Bicentennial Hall 220